NorthStar Asset Management (New Jersey)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.1M Buy
2,587
+141
+6% +$144K 1.26% 22
2026
Q1
$2.25M Sell
2,446
-115
-4% -$117K 1.09% 24
2025
Q4
$2.75M Buy
2,561
+83
+3% +$79.4K 1.24% 25
2025
Q3
$1.89M Buy
2,478
+95
+4% +$70.7K 0.91% 26
2025
Q2
$1.86M Buy
2,383
+199
+9% +$155K 0.98% 26
2025
Q1
$1.8M Buy
2,184
+143
+7% +$119K 1.13% 25
2024
Q4
$1.58M Buy
2,041
+4
+0.2% +$3.31K 1% 25
2024
Q3
$1.8M Buy
2,037
+285
+16% +$256K 1.2% 24
2024
Q2
$1.59M Buy
1,752
+117
+7% +$93.6K 1.1% 25
2024
Q1
$1.27M Buy
1,635
+220
+16% +$157K 0.96% 26
2023
Q4
$825K Buy
+1,415
New +$826K 0.75% 29

Other funds holding LLY

NorthStar Asset Management (New Jersey)'s LLY Position: Q2 2026 in Review

NorthStar Asset Management (New Jersey) increased its Eli Lilly (LLY) stake by 5.8% in Q2 2026, buying an estimated $144K and bringing the position to 2,587 shares worth $3.1M. The position accounts for 1.26% of the portfolio, ranked #22.

NorthStar Asset Management (New Jersey) first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • NorthStar Asset Management (New Jersey) held 2,587 shares of Eli Lilly worth $3.1M as of Q2 2026.
  • NorthStar Asset Management (New Jersey) bought 141 Eli Lilly shares in Q2 2026, an estimated $144K.
  • Eli Lilly made up 1.26% of NorthStar Asset Management (New Jersey)'s portfolio in Q2 2026, its #22 holding.
  • NorthStar Asset Management (New Jersey) first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on NorthStar Asset Management (New Jersey)'s 13F filing for Q2 2026, filed 5 Aug 2026.